2.8280
-0.0120
(-0.42%)
As of 9:39:35 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 7 | 9 |
| Avg. Estimate | 40.2M | 44.29M | 193.12M | 259.48M |
| Low Estimate | 36.72M | 41.22M | 184.95M | 220.3M |
| High Estimate | 46.88M | 46M | 207M | 326.26M |
| Year Ago Sales | 32.75M | 38.06M | 169.6M | 193.12M |
| Sales Growth (year/est) | 22.74% | 16.37% | 13.87% | 34.37% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AYJ.DE | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Related Tickers
T5O0.DE bioXXmed AG
0.6420
-18.11%
BIO3.DE Biotest Aktiengesellschaft
30.00
0.00%
7V0.DE Darwin AG
28.20
+0.71%
NVV1.DE Novavax, Inc.
7.85
-0.53%
88Q.DE 4basebio PLC
12.90
0.00%
BIO.DE Biotest Aktiengesellschaft
42.60
0.00%
9VC.DE Atai Life Sciences N.V.
1.1215
-4.23%
HPHA.DE Heidelberg Pharma AG
2.5500
-3.04%
VX1.DE Vertex Pharmaceuticals Incorporated
426.30
0.00%
NP5.DE Newron Pharmaceuticals S.p.A.
6.87
0.00%